This topic contains a solution. Click here to go to the answer

Author Question: The use of a 6-week daily diary in cognitive therapy in the treatment of depression (Parrish et al., ... (Read 76 times)

go.lag

  • Hero Member
  • *****
  • Posts: 667
The use of a 6-week daily diary in cognitive therapy in the treatment of depression (Parrish et al., 2009 ) has shown the following EXCEPT:
 
  a) Clients reported a reduction in daily sad effects
  b) Clients reported a reduction in negative thoughts and sad effect reactivity to daily stressors
  c) Clients reported an increase in daily positive effects
  d) Clients reported an increase in time spent writing in their dairy

Question 2

Minuchin's focus on dysfunctional states in eating disorders is summarized in his:
 
  a) Family triad theory
  b) Family systems theory
  c) Family interactions theory
  d) Family efficacy theory



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

swimkari

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

d

Answer to Question 2

b




go.lag

  • Member
  • Posts: 667
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


scottmt

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library